PUBLICATION

Cystathione β-synthase regulates HIF-1α stability through persulfidation of PHD2

Authors
Dey, A., Prabhudesai, S., Zhang, Y., Rao, G., Thirugnanam, K., Hossen, M.N., Dwivedi, S.K.D., Ramchandran, R., Mukherjee, P., Bhattacharya, R.
ID
ZDB-PUB-201002-79
Date
2020
Source
Science advances   6(27): (Journal)
Registered Authors
Prabhudesai, Shubhangi N., Ramchandran, Ramani
Keywords
none
MeSH Terms
  • Animals
  • Cystathionine beta-Synthase*/metabolism
  • Hydrogen Sulfide
  • Hypoxia/metabolism
  • Hypoxia-Inducible Factor 1, alpha Subunit*/metabolism
  • Hypoxia-Inducible Factor-Proline Dioxygenases*/metabolism
  • Zebrafish/metabolism
PubMed
32937467 Full text @ Sci Adv
Abstract
The stringent expression of the hypoxia inducible factor-1α (HIF-1α) is critical to a variety of pathophysiological conditions. We reveal that, in normoxia, enzymatic action of cystathionine β-synthase (CBS) produces H2S, which persulfidates prolyl hydroxylase 2 (PHD2) at residues Cys21 and Cys33 (zinc finger motif), augmenting prolyl hydroxylase activity. Depleting endogenous H2S either by hypoxia or by inhibiting CBS via chemical or genetic means reduces persulfidation of PHD2 and inhibits activity, preventing hydroxylation of HIF-1α, resulting in stabilization. Our in vitro findings are further supported by the depletion of CBS in the zebrafish model that exhibits axis defects and abnormal intersegmental vessels. Exogenous H2S supplementation rescues both in vitro and in vivo phenotypes. We have identified the persulfidated residues and defined their functional significance in regulating the activity of PHD2 via point mutations. Thus, the CBS/H2S/PHD2 axis may provide therapeutic opportunities for pathologies associated with HIF-1α dysregulation in chronic diseases.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping